BSEEyantra Ventures LtdHighNeutral
Announced Mon, 25 May · 19:42 IST

Financial Results for the Quarter and Financial Year ended on March 31, 2026

Revenue Growth 20pctPat NegativeRelated Party TransactionsResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹730.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+5.0+9.6+15.1+9.3+8.2+2.2-14.8+0.3
Up moveDown movePending
AI summary

eYantra Ventures Ltd reported standalone revenue of Rs 6,750.21 lakhs for FY2026, up 145% from Rs 2,759.27 lakhs in FY2025. However, standalone net profit fell 84% to Rs 26.53 lakhs from Rs 166.39 lakhs, while consolidated results swung to a net loss of Rs 475.05 lakhs from a profit of Rs 75.07 lakhs in FY2025. The company has subsidiaries including Prismberry Technologies and Eyantra Ventures FZE, plus an associate Neuro and Spine Associates. The auditors issued unmodified opinions on both standalone and consolidated financials. A preferential share issue of 1,87,500 shares at Rs 800 each was completed in January 2025, raising Rs 1,386.85 lakhs out of Rs 1,500 lakhs planned, primarily for working capital and strategic investments.

Likely market impact

Despite strong revenue growth of over 140%, the company faces severe profitability pressure with costs growing faster than sales. The consolidated loss and weak standalone PAT despite massive revenue expansion may concern investors about operational efficiency and cost control.